FDA issues guidance on developing new genetic tests for diagnosis and treatment of disease

The US Food and Drug Administration (FDA) has issued two sets of guidance to drive the design, development and validation of new genetic and genomic-based tests using next generation sequencing (NGS). NGS works by looking at a person’s DNA to detect genomic variations that may determine whether a…